The Annual General Meeting was held in accordance with the published agenda
(announcement dated March 25, 2013). 

The General Meeting took note of the report on the Company’s activities and
adopted the Annual Report 2012. Also, the General Meeting adopted the proposed
decision on use of profit/loss. 

All proposals from the Board of Directors in the agenda’s item 3 were carried:

  1. Authorization for the company to acquire own shares;
  2. Approval of remuneration policy;
  3. Approval of guidelines for incentive schemes;
  4. Approval of remuneration of the Board of Directors;
  5. Reduction of the nominal value of the company’s shares from DKK 3 to DKK 1
     by capital decrease with the necessary change to the Articles of
     Association for reason of consistency;
  6. Authorizations to increase the share capital in article 16a-c in the
     Articles of Association to be extended to 16 April 2018. Additionally, the
     Board of Directors proposes to amend the authorizations to increase the
     share capital with and without pre-emption rights for existing shareholders
     to nominally DKK 100,000,000 and DKK 70.000.000, respectively.
  7. Deleting of article 18b in the Articles of Association with annex 1 and 2
     and consequent changes for reasons of consistency;
  8. Amendment of section 11 in the Articles of Association, consequently, the
     Board of Directors will consist of 3-7 members elected by the General
     Meeting.

All board members were up for election. Thomas Magnussen, Laura von Kobyletzki,
Roar Bjørk Seeger, Torben A. Nielsen and Claus Crone Fuglsang were re-elected.
After the meeting the Board constituted itself with Thomas Magnussen as
chairman and Torben A. Nielsen as vice chairman. 

Deloitte was re-elected auditor for BioPorto A/S.

Gentofte, April 16, 2013

BioPorto A/S

The Board of Directors

Further information:

Christina Thomsen, Investor Relations

Thea Olesen, CEO

Tel. no. (+45) 45 29 00 00, e-mail investor@bioporto.com